An Australian cancer trial that uses precision radiation treatments to help men with advanced prostate cancer have shown promising results.
The experiment, the world's largest, treats nearly 200 men with advanced prostate cancer that has spread to other parts of their body using stereotactic body radiation therapy.
"This new Australian data gives hope for men living with metastatic prostate cancer," Icon Cancer Center in Melbourne radiation oncology, Dr. Pat Bowden said.
Treatment uses radiation in high doses to target small areas of cancer while leaving healthy tissue.
Up to 50 percent of patients are free from treatment increases for two years and no patients experience severe long-term side effects, results published in the International Journal of Cancer show.
"Unfortunately this is an incurable condition with a life expectancy of around five years. It is very promising to see precision radiation therapy delay the development of treatment for more than two years," he said.
Research shows that precision radiation therapy in cancer treatment can improve quality and duration and life, the doctor said.
Up to 18,000 men receive a diagnosis of prostate cancer every year and 15,000 men now live with metastatic prostate cancer.
This research was led by experts from Icon Cancer Center and funded by Epworth Medical Foundation and EJ Whitten Foundaiton.
Australian Associated Press